Randomized, Double-blind, Parallel Group, Placebo-controlled, Fixed-dose of Lu AE58054 In Patients with Mild - Moderate Alzheimer's Disease Treated with Donepazil; Study 2

Project Details

StatusFinished
Effective start/end date8/12/14 → 31/12/19

Funding

  • Lundbeck Pharmaceuticals: $105,614.90

Keywords

  • Aging & Alzheimers, Biotechnology & Drug Development